Our results identified high tumor expression of DNMT1 in TNBC and low tumor expression of DNMT 1 in luminal A type, concordant with a previous study in which DNMT1 expression was reported to be increased in breast cancer compared to other benign lesions, especially in ER-negative breast cancer [4]. This evidence concerns the gene DNMT1 and breast carcinoma.